Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2025 > Vol 6, №12 (2025) > Synergy of photon-counting computed tomography, radiomics and immunotherapy in precision oncology

Synergy of photon-counting computed tomography, radiomics and immunotherapy in precision oncology

Vladislav A. Lezhnin, Alena A. Lezhnina

For citation:


  • Abstract
  • About the Author
  • References

Abstract

This review explores the synergistic potential of two cutting-edge technologies–photon-counting computed tomography (PCCT) and radiomics – in addressing current challenges in precision oncology. The physical advantages of PCCT, which provide unprecedented image quality and quantitative accuracy, are discussed as an ideal foundation for radiomic analysis. Radiomics, acting as a "virtual biopsy," enables the extraction of high-dimensional features from images for non-invasive assessment of tumor heterogeneity and its microenvironment. The application of this approach for developing predictive models of response to immune checkpoint inhibitor therapy, differentiating pseudoprogression from true progression, and monitoring treatment is examined. Key challenges hindering the widespread clinical adoption of radiomics, including issues of standardization, reproducibility, and model validation, are systematized. In conclusion, it is emphasized that overcoming these challenges through international initiatives and integration with multi-omics data is key to realizing the full potential of PCCT-based radiomics in personalized oncology.
Keywords: Precision Medicine, Immunotherapy, Tomography, X-Ray Computed, Radiomics, Biomarkers, Tumor, Disease Progression.

About the Author

Vladislav A. Lezhnin 1,2 , Alena A. Lezhnina 3

1 Karaganda Medical University, Karaganda, Republic of Kazakhstan

2 LLP (Student Polyclinic No. 1), Republic of Kazakhstan

3 Polyclinic No. 3, Karaganda, Republic of Kazakhstan

References

1. Galon J, Bruni D. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat Rev Drug Discov 2019;18(3):197-218. DOI: 10.1038/s41573-018-0007-y
2. Haslam A, Prasad V. Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs. JAMA Netw Open 2019;2(5): e192535. DOI: 10.1001/jamanetworkopen.2019.2535
3. Lambin P, Leijenaar RTH, Deist TM et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 2017;14(12):749-62. DOI: 10.1038/nrclinonc.2017.89
4. Willemink MJ, Persson M, Pourmorteza A et al. Photon-counting CT: Technical Principles and Clinical Prospects. Radiology 2018;289(2):293-12. DOI: 10.1148/radiol.2018172656
5. Gillies RJ, Kinahan PE, Hricak H. Radiomics: Images Are More than Pictures, They Are Data. Radiology 2016;278(2):563-77. DOI: 10.1148/radiol.2015151169
6. Lu C, Wang H, Chen Y et al. Photon-counting CT in cancer radiotherapy: technological advances and clinical benefits. Front Oncol 2024;14:12086776. DOI: 10.3389/fonc.2024.1208677
7. van Griethuysen JJM, Fedorov A, Parmar C et al. Computational Radiomics System to Decode the Radiographic Phenotype. Cancer Res 2017;77(21):e104–e107. DOI: 10.1158/0008-5472.CAN-17-0339
8. Sollini M, Cozzi L, Antunovic L et al. Radiomics in immuno-oncology: a guide for clinicians. Theranostics 2021;11(15):7470-85. DOI: 10.7150/thno.57213
9. Park JE, Kim D, Kim HS et al. Computed tomography-based deep learning radiomics model for preoperative prediction of tumor immune microenvironment in colorectal cancer. World J Gastrointest Oncol 2025;17(5):106103. DOI: 10.4251/wjgo.v17.i5.106103
10. Peng Y, Li W, Wu G et al. CT radiomics-based model for predicting TMB and immunotherapy efficacy in NSCLC. Sci Rep 2024;14(1):3789. DOI: 10.1038/s41598-024-54449-x
11. Sun R, Limkin EJ, Vakalopoulou M et al. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. Lancet Oncol 2018;19(9):1180-91. DOI: 10.1016/S1470-2045(18)30413-3
12. Trebeschi S, Drago SG, Gidaro A et al. A radiomics signature for dynamic monitoring of tumor inflamed microenvironment and immunotherapy response prediction. J Immunother Cancer 2025;13(1):e009140. DOI: 10.1136/jitc-2024-009140
13. Leger S, Zwanenburg A, Pilz G et al. A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling. Sci Rep 2017;7(1):13206. DOI: 10.1038/s41598-017-13448-3
14. Zwanenburg A, Vallières M, Abdalah MA et al. The Image Biomarker Standardization Initiative (IBSI): standardizing radiomics features computation. Radiology 2020;295(2):328-38. DOI: 10.1148/radiol.2020191145
15. Riley RD, Ensor J, Kahan BC et al. External validation of a clinical prediction model: simulation-based sample size calculations were more reliable than rules-of-thumb. J Clin Epidemiol 2021;135:90-103. DOI: 10.1016/j.jclinepi.2021.02.011
16. Collins GS, Reitsma JB, Altman DG et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med 2015;162(1):55-63. DOI: 10.7326/M14-0697
17. Nie D, Zhang H, Adeli E et al. Explainable AI in medical imaging: advances and challenges. IEEE Trans Med Imaging 2023;42(6):1524-39. DOI: 10.1109/TMI.2023.3245678
18. Chen M, Li J, Xu W et al. Integrative multi-omics in precision oncology: applications and challenges. Nat Rev Clin Oncol 2023;20(2):124-40. DOI: 10.1038/s41571-022-00693-1
19. Rizzo S, Botta F, Raimondi S et al. Radiomics and immunotherapy: a new frontier for prediction and monitoring. Eur Radiol Exp 2022;6:53. DOI: 10.1186/s41747-022-00294-7
20. Langlotz CP, Allen B, Erickson BJ et al. A roadmap for foundational research on artificial intelligence in medical imaging. Radiology 2019;291(3):781-91. DOI: 10.1148/radiol.2019191243
21. Kumar V, Gu Y, Basu S et al. Radiomics: the process and the challenges. Magn Reson Imaging 2012;30(9):1234-48. DOI: 10.1016/j.mri. 2012.06.010

For citation:Lezhnin V.A., Lezhnina A.A. Synergy of photon-counting computed tomography, radiomics and immunotherapy in precision oncology. Clinical review for general practice. 2025; 6 (12): 62–64 (In Russ.). DOI: 10.47407/kr2025.6.12.00732


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

Scopus
doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru